Genetics of Paget's Disease of Bone

被引:24
作者
Ralston, Stuart H. [1 ]
Albagha, Omar M. E. [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Bone & Rheumatol Res Grp, Edinburgh EH4 2XU, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
Paget's disease of bone; Osteitis deformans; Osteoclast; Genetic; SQSTM1; RIN3; Optineurin; RANK; RANKL; Osteoprotegerin; DC-STAMP; TM7SF4; Macrophage colony stimulating factor; M-CSF; CSF1; Bone resorption; Fracture; NF kappa B; Osteosarcoma; INCLUSION-BODY MYOPATHY; UBIQUITIN-ASSOCIATED DOMAIN; GENOME-WIDE ASSOCIATION; SIGNAL PEPTIDE; GENOTYPE-PHENOTYPE; ENCODING RANK; DC-STAMP; MUTATIONS; SQSTM1; TNFRSF11A;
D O I
10.1007/s11914-014-0219-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paget's disease of bone (PDB) is a common condition, which is characterised by focal areas of increased and disorganized bone remodeling. Genetic factors play an important role in the disease. In some cases, Paget's disease is inherited in an autosomal dominant manner and the most common cause for this is a mutation in the SQSTM1 gene. Other familial cases have been linked to the OPTN locus on Chromosome 10p13 and still other variants have been identified by genome wide association studies that lie within or close to genes that play roles in osteoclast differentiation and function. Mutations in TNFRSF11A, TNFRSF11B and VCP have been identified in rare syndromes with PDB-like features. These advances have improved understanding of bone biology and the causes of PDB. The identification of genetic markers for PDB also raises the prospect that genetic profiling could identify patients at high risk of developing complications, permitting enhanced surveillance and early therapeutic intervention.
引用
收藏
页码:263 / 271
页数:9
相关论文
共 67 条
[51]  
Poór G, 2006, J BONE MINER RES, V21, P1545, DOI [10.1359/JBMR.060704, 10.1359/jbmr.060704]
[52]  
RALSTON SH, 1993, BRIT MED J, V306, P332, DOI 10.1136/bmj.306.6873.332-c
[53]   Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone [J].
Ralston, Stuart H. ;
Afzal, Muhammad A. ;
Helfrich, Miep H. ;
Fraser, William D. ;
Gallagher, James A. ;
Mee, Andrew ;
Rima, Bert .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (04) :569-577
[54]   Paget's Disease of Bone [J].
Ralston, Stuart H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07) :644-650
[55]   Pathogenesis of Paget Disease of Bone [J].
Ralston, Stuart H. ;
Layfield, Rob .
CALCIFIED TISSUE INTERNATIONAL, 2012, 91 (02) :97-113
[56]  
REBEL A, 1974, REV RHUM, V41, P767
[57]   Panostotic Expansile Bone Disease With Massive Jaw Tumor Formation and a Novel Mutation in the Signal Peptide of RANK [J].
Schafer, Anne L. ;
Mumm, Steven ;
El-Sayed, Ivan ;
McAlister, William H. ;
Horvai, Andrew E. ;
Tom, Andrea M. ;
Hsiao, Edward C. ;
Schaefer, Frederick V. ;
Collins, Michael T. ;
Anderson, Mark S. ;
Whyte, Michael P. ;
Shoback, Dolores M. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (04) :911-921
[58]   Mutant p62P392L Stimulation of Osteoclast Differentiation in Paget's Disease of Bone [J].
Sundaram, Kumaran ;
Shanmugarajan, Srinivasan ;
Rao, D. Sudhaker ;
Reddy, Sakamuri V. .
ENDOCRINOLOGY, 2011, 152 (11) :4180-4189
[59]  
Taylor Adam, 2011, Small GTPases, V2, P131
[60]   Incidence and natural history of Paget's disease of bone in England and Wales [J].
Van Staa, TP ;
Selby, P ;
Leufkens, HGM ;
Lyles, K ;
Sprafka, JM ;
Cooper, C .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (03) :465-471